Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 3 EP applications Peter Richard Roth has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12177119

Crystal form H of imatinib mesylate

IPC classification:
A61K 31/506, A61P 35/00, C07D 401/04, C07D 401/14
Applicant:
Novartis AG
Agent:
Peter Richard Roth, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12177131

G, I and K crystal forms of imatinib mesylate

IPC classification:
A61K 31/506, A61P 35/00, C07D 401/04
Applicant:
Novartis AG
Agent:
Peter Richard Roth, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13718720

METHOD OF TREATING GASTROINTESTINAL STROMAL TUMORS

IPC classification:
A61K 31/4709, A61K 31/506, A61P 35/00
Applicant:
Novartis AG
Agent:
Peter Richard Roth, Novartis Pharma AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature